掌趣科技(300315.SZ):《一拳超人:最強之男》上線以來至今年4月底充值流水達9.04億元
格隆匯5月15日丨掌趣科技(300315.SZ)公佈,公司遊戲產品《一拳超人:最強之男》於2019年6月19日在中國大陸上線,之後陸續在港澳台地區上線。截至2020年4月30日,該遊戲產品累計收入首次達到公司最近一個會計年度經審計營業收入的30%。
2019年6月19日-2020年4月30日,一拳超人:最強之男用户數量1889.224萬,活躍用户數1889.224萬,付費用户數146.7735萬,ARPU值615.99元,充值流水約9.04億元,已確認收入約4.99億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.